Notice Number: NOT-AT-06-006

Key Dates
Release Date: July 14, 2006
Letter of Intent Receipt Dates: October 16, 2006; October 15, 2007
Application Submission Dates: November 14, 2006 and 2007

Issued by
National Center for Complementary and Alternative Medicine (NCCAM), (http://www.nccam.nih.gov/)

The National Center for Complementary and Alternative Medicine published PAR-06-372, CAM at Minority or Health Disparities Research Centers on April 27, 2006 (http://grants.nih.gov/grants/guide/pa-files/PAR-06-372.html).  The purpose of this Notice is to clarify issues regarding direct cost limits and allowable project period length of the NCCAM R21 mechanism used in PAR-06-372.

The R21 awards are exploratory/developmental research grants for support of pilot and feasibility research designed to provide investigators with an opportunity to produce preliminary data in support of a larger project that may be submitted in the future as a research project (R01) grant application. Two NCCAM R21 funding mechanisms (http://nccam.nih.gov/research/instructions/r21/index.htm) are available:  (1) Basic and Preclinical Research on Complementary and Alternative Medicine (PA-06-315); and, (2) NCCAM Exploratory/Developmental Grant for Clinical Studies (PA-06-091).  Section IV.6 of the PAR-06-372 erroneously specifies the same direct cost limits and allowable project period length for clinical R21 applications and pre-clinical R21 applications.  Applicants are advised to check the website referenced above for the most current NCCAM R21 announcements and to abide by the application guidance, allowable project period length, and direct cost limits for the relevant R21 program announcement.

Inquiries

If there are questions regarding PAR-06-372, CAM at Minority or Health Disparities Research Centers, please contact:

Morgan N. Jackson, M.D., M.P.H.
Director, Office of Special Populations
Division of Extramural Research and Training
National Center for Complementary and Alternative Medicine
6707 Democracy Boulevard, Suite 401
Bethesda, MD 20892-5475
Phone:  301-402-1278
E-mail: [email protected]